Latest news
CORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal - TipRanksTipRanks · Sat, 01 Aug 2026 16:03:02 GMTCORE Biomedicine Raises $21 Million Series A and Secures AMED Grant to Advance Lineage-Based Cancer Drugs - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMTCORE Biomedicine Secures Global Rights to Eisai Oncology Portfolio to Advance Precision Cancer Therapies - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMT